Pros: Some individual contributors are still trying to do good work despite circumstances. Office locations are decent.

Cons: This company is in a death spiral. Employees watched their equity crater 80% in value (September 2025 reports), while leadership spins it as "strategic repositioning." The benefits that once attracted talent have eroded; competitive compensation is a distant memory. The "Google DNA" has left the building either voluntarily or via layoffs, and those that haven't yet been able to find other roles are beginning to become tainted in the eyes of recruiters in my network. Current products are me-too offerings entering saturated markets years late, burdened by technical debt and built by teams whose morale has been systematically destroyed. Leadership infighting is visible at every level. The ongoing HIPAA violation lawsuit, alleging cover-ups affecting 25,000+ patients, should terrify any pharma partner – this company can't execute on products and poses compliance risks. The August 2025 device division shutdown, after years of investment, shows the pattern: pivot, burn cash, fail, pivot again. Now pivoting to "AI and precision health" – the same vague promises, just following different buzzwords. The LLC-to-C-corp restructuring could signal desperation for any funding at any terms, or preparation for asset sales and wind-down. The innovative, mission-driven culture that once existed has been replaced by bureaucratic paralysis, risk aversion, and executives who seem contemptuous of their own workforce. Decision-making is glacial, initiatives die in endless approval loops, and the few remaining optimists seem detached from reality.

Pros: Compensation and perks used to be good. They are still decent, but not at the level of others in Alphabet. Some smart engineers and scientists still remain. Some links to the Google software infrastructure and training represent good growth opportunities for those for whom the potential skill set is useful.

Cons: Management is a complete fiasco, with limited responsibility for decisions and product vision. Consistent blame is given to junior team members who were often not even aware of a specific decision until they are blamed. There is an obsession with chasing short-term profits (e.g., C19) over fixing technical debt and supporting long-term products to help differentiate the company from other health technology start-ups. Well-documented issues, such as those articulated in Business Insider and Science press, exist. For the latter, the CEO suggested that Verily's medical products do not require in-vivo testing, which is utterly laughable. There is an inability to accept that any outcome is not extremely good, and pressure on junior ICs to not present any item that may suggest a product is not perfect, leading to the inability to build distinct, useful products for their customers. A bizarre focus on a partnership model is often sold to partners on immature products, which are often under-supported and poorly delivered. Promotion opportunities are extremely limited. Despite underlying Google infrastructure, somehow the faculties, strategy, legal, and HR are all under-supported and overworked.

Pros: Some of the most brilliant technical staff I've seen anywhere. Favored projects are generously supported. The CEO is amazing at securing funding. Some projects have potential to be socially beneficial.

Cons: The company is not very good at making use of employees' skills. Management seems to avoid hard decisions. Technically weak projects can be pushed forward for years after they should have been abandoned. Employees can't trust statements from management; everything is happy talk. The company doesn't value good ideas, while too many bad ideas get high-level support. There is no meaningful mechanism for rewarding good managers. Employee evaluations are very subjective and can vary wildly by manager. Diversity, inclusion, and sustainability initiatives are very limited and largely pro forma. Staff turnover seems quite high. Direction changes rapidly, with different parts of the company rowing in different directions.